Journal
PROTEIN ENGINEERING DESIGN & SELECTION
Volume 29, Issue 12, Pages 583-593Publisher
OXFORD UNIV PRESS
DOI: 10.1093/protein/gzw049
Keywords
complex; G protein; G protein-coupled receptor; GPCR; G(s); mini G protein; mini-G(s)
Funding
- Heptares Therapeutics Ltd
- Medical Research Council [MRC U105197215]
- MRC [MC_U105197215] Funding Source: UKRI
- Medical Research Council [MC_U105197215] Funding Source: researchfish
Ask authors/readers for more resources
G protein-coupled receptors (GPCRs) modulate cytoplasmic signalling in response to extracellular stimuli, and are important therapeutic targets in a wide range of diseases. Structure determination of GPCRs in all activation states is important to elucidate the precise mechanism of signal transduction and to facilitate optimal drug design. However, due to their inherent instability, crystallisation of GPCRs in complex with cytoplasmic signalling proteins, such as heterotrimeric G proteins and beta-arrestins, has proved challenging. Here, we describe the design of a minimal G protein, mini-G(s), which is composed solely of the GTPase domain from the adenylate cyclase stimulating G protein G(s). Mini-G(s) is a small, soluble protein, which efficiently couples GPCRs in the absence of G beta gamma. subunits. We engineered mini-Gs, using rational design mutagenesis, to form a stable complex with detergent-solubilised beta(1)-adrenergic receptor (beta(1)AR). Mini G proteins induce similar pharmacological and structural changes in GPCRs as heterotrimeric G proteins, but eliminate many of the problems associated with crystallisation of these complexes, specifically their large size, conformational dynamics and instability in detergent. They are therefore novel tools, which will facilitate the biochemical and structural characterisation of GPCRs in their active conformation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available